0.1864
price up icon6.76%   0.0118
after-market After Hours: .18 -0.0064 -3.43%
loading
Vivos Therapeutics Inc stock is traded at $0.1864, with a volume of 4.37M. It is up +6.76% in the last 24 hours and down -59.67% over the past month. Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
See More
Previous Close:
$0.1746
Open:
$0.164
24h Volume:
4.37M
Relative Volume:
0.39
Market Cap:
$3.75M
Revenue:
$19.57M
Net Income/Loss:
$-25.12M
P/E Ratio:
-0.0806
EPS:
-2.3114
Net Cash Flow:
$-19.71M
1W Performance:
-17.12%
1M Performance:
-59.67%
6M Performance:
-87.06%
1Y Performance:
-95.76%
1-Day Range:
Value
$0.164
$0.1893
1-Week Range:
Value
$0.1575
$0.4559
52-Week Range:
Value
$0.1575
$4.4124

Vivos Therapeutics Inc Stock (VVOS) Company Profile

Name
Name
Vivos Therapeutics Inc
Name
Phone
(866)908-4867
Name
Address
7921 SOUTHPARK PLAZA,, LITTLETON
Name
Employee
268
Name
Twitter
Name
Next Earnings Date
2026-08-18
Name
Latest SEC Filings
Name
VVOS's Discussions on Twitter

Compare VVOS vs ABT, MDT, SYK, BSX, EW

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
VVOS icon
VVOS
Vivos Therapeutics Inc
0.1864 5.61M 19.57M -25.12M -19.71M -2.3114
ABT icon
ABT
Abbott Laboratories
108.33 197.51B 46.59B 5.41B 7.38B 3.0938
MDT icon
MDT
Medtronic Plc
94.17 118.14B 36.36B 4.84B 5.43B 3.7261
SYK icon
SYK
Stryker Corp
303.13 125.70B 25.27B 3.34B 4.57B 8.6334
BSX icon
BSX
Boston Scientific Corp
47.80 71.55B 20.62B 3.56B 3.48B 2.3847
EW icon
EW
Edwards Lifesciences Corp
89.90 51.78B 6.30B 1.07B 1.09B 1.8406

Vivos Therapeutics Inc Stock (VVOS) Latest News

pulisher
Sep 04, 2026

Vivos Therapeutics Inc (NASDAQ: VVOS) Share Price, VVOS Stock News, VVOS Share Price & Updates - Kalkine

Sep 04, 2026
pulisher
Sep 03, 2026

Vivos Therapeutics (VVOS) investor lists 122,963 shares, under 5% - Stock Titan

Sep 03, 2026
pulisher
Sep 01, 2026

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Sep 01, 2026
pulisher
Sep 01, 2026

Vivos Therapeutics to Present at the 2026 Moody Capital Solutions Disruptive Growth & Life Sciences Conference - TradingView

Sep 01, 2026
pulisher
Aug 31, 2026

Vivos Therapeutics Surges as Investors Weigh Nevada Growth Updates and Florida Expansion Plan - Moomoo

Aug 31, 2026
pulisher
Aug 28, 2026

Vivos Therapeutics partners with Florida cardiology group for sleep center - Investing.com

Aug 28, 2026
pulisher
Aug 28, 2026

Vivos Therapeutics partners with Florida cardiology group for sleep center By Investing.com - Investing.com UK

Aug 28, 2026
pulisher
Aug 28, 2026

Vivos Therapeutics and South Palm Cardiovascular Associates Sign Definitive Agreements to Launch Regional Sleep Testing and Treatment Center - marketscreener.com

Aug 28, 2026
pulisher
Aug 27, 2026

Vivos Therapeutics Inc. (VVOS) Peer Comparison – Compare with Others - Value Research

Aug 27, 2026
pulisher
Aug 26, 2026

Vivos Therapeutics (VVOS) grants 250K shares, 150K options - Stock Titan

Aug 26, 2026
pulisher
Aug 25, 2026

Vivos Therapeutics reports 212% rise in Nevada patient referrals By Investing.com - Investing.com Canada

Aug 25, 2026
pulisher
Aug 25, 2026

Vivos Therapeutics Reports Record New Patient Referrals at its Nevada Sleep & Airway Medicine Centers - Barchart.com

Aug 25, 2026
pulisher
Aug 25, 2026

12 Health Care Stocks Moving In Tuesday's After-Market Session - Sahm

Aug 25, 2026
pulisher
Aug 21, 2026

Vivos Therapeutics Inc (VVOS) Stock News Today - TradingKey

Aug 21, 2026
pulisher
Aug 20, 2026

Vivos Therapeutics opens Henderson facility with $10M capacity - Investing.com

Aug 20, 2026
pulisher
Aug 20, 2026

Vivos Therapeutics Opens Nevada Sleep Treatment Center - marketscreener.com

Aug 20, 2026
pulisher
Aug 20, 2026

Vivos Therapeutics Opens New Sleep Testing and Treatment Facility in Nevada to Meet Rapidly Growing Patient Demand for Sleep Apnea Testing and Treatment - The Manila Times

Aug 20, 2026
pulisher
Aug 20, 2026

Vivos Therapeutics opens Henderson facility with $10M capacity By Investing.com - Investing.com Canada

Aug 20, 2026
pulisher
Aug 20, 2026

Vivos Therapeutics Opens New Henderson Sleep Center, Expects Capacity to More Than Double to Over $10 Million Annually - Moomoo

Aug 20, 2026
pulisher
Aug 20, 2026

Vivos expects its Nevada sleep center to more than double annual capacity to $10M+ - Stock Titan

Aug 20, 2026
pulisher
Aug 18, 2026

Vivos Therapeutics Inc (VVOS) (Q2 2026) Earnings Call Highlights: Revenue Surges 35% on ... By GuruFocus - Investing.com Canada

Aug 18, 2026
pulisher
Aug 17, 2026

Vivos Therapeutics shares slide after Q2 revenue falls short of forecasts - Yahoo Finance

Aug 17, 2026
pulisher
Aug 17, 2026

Vivos Therapeutics stock falls 6% on second quarter revenue miss By Investing.com - Investing.com Canada

Aug 17, 2026
pulisher
Aug 17, 2026

Vivos Therapeutics stock falls 6% on second quarter revenue miss - Investing.com

Aug 17, 2026
pulisher
Aug 17, 2026

Conferencia de resultados del 2T de 2026 de Vivos Therapeutics (VVOS): los ingresos suben un 35%, persisten los riesgos de liquidez - TradingKey

Aug 17, 2026
pulisher
Aug 17, 2026

Vivos Therapeutics (VVOS) Q2 2026 Earnings Call: Umsatz steigt um 35 %, Liquiditätsrisiken bestehen weiterhin - TradingKey

Aug 17, 2026
pulisher
Aug 15, 2026

Vivos Therapeutics partners with SPCVA to form AIM Florida - scanx.trade

Aug 15, 2026
pulisher
Aug 15, 2026

Vivos Therapeutics, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance

Aug 15, 2026
pulisher
Aug 15, 2026

Vivos Therapeutics Q2 2026 Earnings Call Transcript - MarketBeat

Aug 15, 2026
pulisher
Aug 15, 2026

Vivos gets Washington license to manufacture IsoPet - scanx.trade

Aug 15, 2026
pulisher
Aug 14, 2026

Vivos Therapeutics Reports Q2 2026 Results: Full Earnings Call Transcript - Benzinga

Aug 14, 2026
pulisher
Aug 14, 2026

Earnings call transcript: Vivos Therapeutics posts strong Q2 2026 revenue growth - Investing.com Canada

Aug 14, 2026
pulisher
Aug 14, 2026

Transcript : Vivos Therapeutics, Inc., Q2 2026 Earnings Call, Aug 14, 2026 - marketscreener.com

Aug 14, 2026
pulisher
Aug 14, 2026

Vivos Therapeutics, Inc. (VVOS) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance

Aug 14, 2026
pulisher
Aug 14, 2026

Vivos Therapeutics reports 35% revenue increase in Q2 2026 By Investing.com - Investing.com Canada

Aug 14, 2026
pulisher
Aug 14, 2026

Vivos Therapeutics Q2 revenue up 35%; targets positive cash flow by late 2026 - scanx.trade

Aug 14, 2026
pulisher
Aug 14, 2026

Vivos Therapeutics reports 35% revenue increase in Q2 2026 - Investing.com

Aug 14, 2026
pulisher
Aug 14, 2026

Vivos Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 14, 2026
pulisher
Aug 14, 2026

Vivos Therapeutics Q2 revenue rises 35% on service growth - TradingView

Aug 14, 2026
pulisher
Aug 14, 2026

Vivos Therapeutics Reports 35% Quarterly Revenue Growth, Rising Patient Demand and Second Quarter 2026 Results - Quiver Quantitative

Aug 14, 2026
pulisher
Aug 14, 2026

Vivos Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Update - Yahoo Finance

Aug 14, 2026
pulisher
Aug 14, 2026

Vivos Therapeutics, Inc. Q2 2026: Revenue $5.15M, EPS $(0.31) — 10-Q Summary - TradingView

Aug 14, 2026
pulisher
Aug 14, 2026

Vivos Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 14, 2026
pulisher
Aug 14, 2026

Armistice Capital discloses 4.99% VVOS position in Vivos Therapeutics (VVOS) - Stock Titan

Aug 14, 2026
pulisher
Aug 14, 2026

Vivos Therapeutics schedules Q2 2026 results, conference call - scanx.trade

Aug 14, 2026
pulisher
Aug 14, 2026

Vivos to discuss collaborations’ anticipated effect on revenue growth and cash burn - Stock Titan

Aug 14, 2026
pulisher
Aug 14, 2026

Vivos Therapeutics Schedules Release of Second Quarter 2026 Financial Results and Conference Call - marketscreener.com

Aug 14, 2026
pulisher
Aug 13, 2026

Vivos Therapeutics (VVOS) Edges Higher as Penny Stock Holds Support Near $0.29High Reward Trades - Vinanet

Aug 13, 2026
pulisher
Aug 11, 2026

Form 8K Vivos Therapeutics Inc For: 11 August By Investing.com - Investing.com Australia

Aug 11, 2026
pulisher
Aug 11, 2026

Vivos Therapeutics Strengthens IP for Sleep Apnea Devices - TipRanks

Aug 11, 2026
pulisher
Aug 11, 2026

Vivos Oral Appliance Shows Improvement in Insomnia Severity - Sleep Review

Aug 11, 2026

Vivos Therapeutics Inc Stock (VVOS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
ZBH ZBH
$98.07
price down icon 0.86%
STE STE
$224.59
price down icon 0.99%
PHG PHG
$25.89
price down icon 0.61%
$68.86
price down icon 1.23%
$87.90
price down icon 2.02%
EW EW
$89.90
price up icon 0.13%
Cap:     |  Volume (24h):